Carrera Capital Advisors Abb Vie Inc. Transaction History

Carrera Capital Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 07, 2025	BUY	$169.2 - $216.66 $25,887 - $33,148	153 Added 12.8%	1,348 $282 Million
Q4 2024 Feb 06, 2025	SELL	$164.99 - $203.87 $1.86 Million - $2.3 Million	-11,285 Reduced 90.42%	1,195 $212 Million
Q3 2024 Nov 05, 2024	BUY	$163.84 - $199.33 $343,080 - $417,397	2,094 Added 20.16%	12,480 $2.46 Billion
Q2 2024 Aug 27, 2024	BUY	$154.79 - $180.76 $1.61 Million - $1.88 Million	10,386 New	10,386 $1.78 Billion

4,489

1.28B

16.9M

15.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $414B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Carrera Capital Advisors, based on Form 13F filings with the SEC.

Stay updated on Carrera Capital Advisors with notifications on news.